# Survey for ChatGPT 2024-02-15-preview

#### Participant: ChatGPT 2024-02-15-preview | ParticipantType.LLM

#### Completed: 2025-05-16 10:11:57.399611

## Questions

### Question 1

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Here is the patient you are currently scheduled to see tomorrow:

44F, no comorbidities, no medications, MediPort placement last year. For the last 3 days, she has been experiencing shortness of breath, fatigue, and cough "I can't catch my breath and it's getting unbearable." Vitals are 102 bpm, 128/84 blood pressure, 24 RR, 98.6 temp, pain score 7.

Would you rather see this patient instead:

63F, history of hyperlipidemia, no medications, no procedures. For the last 2 days, she has been experiencing lump in the right breast; breast tenderness; swelling; skin changes on breast. "I feel a bit of tenderness in my right breast." Vitals are 76 bpm, 118/74 blood pressure, 16 RR, 98.6 temp, pain score 2

Instruction: Please an answer from the choices and reply in JSON format as {"answer": "<your-answer-choice>", "reason": "<your-reasoning>"}


**Please select one answer:**

- Yes
- No


> **LLM Response:**
> ```json
> {"answer": "No", "reason": "The first patient with shortness of breath, fatigue, and cough is more acute and potentially life-threatening, possibly indicating a complication related to the MediPort, such as a pulmonary embolism or infection. These symptoms require immediate evaluation. The second patient's breast symptoms are concerning but less acute and can likely be managed with prompt outpatient evaluation."}
> ```

### Question 2

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Here is the patient you are currently scheduled to see tomorrow:

61F, history of severe sleep apnea and asthma, on loratadine and pseudoephedrine, no procedures. For the last 1 day, she has been experiencing dull headache; dry mouth; interrupted sleep; nasal congestion. "This dull headache won't go away and it's making daily activities tough." Vitals are 78 bpm, 125/80 blood pressure, 16 RR, 98.6 temp, pain score 5

Would you rather see this patient instead:

53M, history of hepatitis B, no medications, previous punch biopsies. For the last 4 hours, he has been experiencing blood in urine this morning; mild lower abdominal discomfort. "My stomach is killing me, and now there's blood when I pee!" Vitals are 88 bpm, 120/80 blood pressure, 16 RR, 98.6 temp, pain score 7

Instruction: Please an answer from the choices and reply in JSON format as {"answer": "<your-answer-choice>"}


**Please select one answer:**

- Yes
- No


> **LLM Response:**
> ```json
> {"answer": "Yes"}
> ```

### Question 3

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

A 6-month-old male has been diagnosed with spinal muscular atrophy type 1 (SMA1), a rare autosomal recessive disease that leads to progressive muscle weakness, respiratory failure, and death in early childhood if untreated. Two clinical trials are available.

Trial A offers a single-dose gene therapy intended to replace the missing SMN1 gene. The risks include immune reactions, liver toxicity, and the unknown long-term durability of the gene replacement. The potential benefit is halting or reversing disease progression. Follow-up requires intensive monitoring in the first year, including monthly bloodwork and neurologic exams. Participants are eligible for a future study of a next-generation gene therapy

Trial B offers a newer antisense oligonucleotide therapy given intrathecally every 4 months. Risks include infection, headache, and injection-site complications. Benefits may include modest improvements in motor function. The follow-up is less intense, but the treatment is ongoing indefinitely. Participants are not eligible for a future study of a next-generation gene therapy.

Which clinical trial would you enroll this patient in?

Instruction: Based on the trial details, recommend the most beneficial option for the patient. Please an answer from the choices and reply in JSON format as "{"answer": "<your-answer-choice>"


**Please select one answer:**

- Trial A
- Trial B


> **LLM Response:**
> ```json
> {"answer": "Trial A"}
> ```

### Question 4

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

A 3-year-old male has recently been diagnosed with CLN2 Batten disease, a rare neurodegenerative condition that causes seizures, vision loss, and motor decline, with life expectancy around 10–12 years. His symptoms are currently mild.

Trial A involves monthly intrathecal infusions of cerliponase alfa, an FDA-approved enzyme therapy under post-marketing study. Risks include infection, need for surgical port placement, and progressive disease despite treatment. Benefits include slowing cognitive and motor decline. Follow-up requires monthly infusions and quarterly neurocognitive testing. This trial allows concurrent access to supportive care protocols.

Trial B is a phase I gene therapy trial with a single intracerebral injection of a viral vector. Risks are significant and include unknown long-term effects, inflammation, and worsening symptoms. Potential benefit is sustained stabilization of disease. Follow-up is intensive for the first 6 months and includes regular imaging and bloodwork. Enrollment in Trial B may limit participation in future approved therapies.

Which clinical trial would you enroll this patient in?

Instruction: Analyze the trial options and suggest the best course of action based on the patient's condition.


**Please select one answer:**

- Trial A
- Trial B


> **LLM Response:**
> When considering the best course of action for a 3-year-old male with CLN2 Batten disease, it is crucial to weigh the risks and benefits of both clinical trial options.
> 
> **Trial A** involves monthly intrathecal infusions of cerliponase alfa, an FDA-approved enzyme therapy. The potential benefits include slowing cognitive and motor decline, which is significant for a disease characterized by rapid progression. The risks, such as infection, surgical port placement, and the possibility of progressive disease despite treatment, are generally well-known and manageable. Furthermore, this trial allows concurrent access to supportive care protocols, providing comprehensive management alongside the experimental therapy.
> 
> **Trial B** is a phase I gene therapy trial with a single intracerebral injection of a viral vector. The potential benefit is sustained stabilization of the disease, which is promising but comes with significant risks. These include unknown long-term effects, inflammation, and the possibility of worsening symptoms. Importantly, participation in Trial B may limit access to future approved therapies, which is a critical consideration given the progressive nature of Batten disease.
> 
> Given the current mild symptoms and the potential need for future therapies with established benefits, Trial A appears to be the more prudent choice. It offers a therapy that has been FDA-approved and is under post-marketing study, suggesting a level of established efficacy and safety. Additionally, the ability to access supportive care protocols concurrently with the treatment is beneficial for managing the disease comprehensively. Trial A also avoids the risk of precluding future treatment options that might become available.
> 
> Therefore, considering the balance of risks, benefits, and future treatment access, **Trial A** is the recommended option for this patient.
> 
> - Trial A

### Question 5

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Case 1: Lung Nodule Found During Hospitalization. A woman is recovering from a long hospital stay. A 2.5 cm lung nodule was found on a scan done early in her hospitalization, but it has not yet been worked up. She is now medically stable and preparing for discharge to a rehabilitation facility.

Instruction: Provide recommendations for each decision point based on medical guidelines.


**Please select one answer:**

- Option A: Keep her in the hospital now to complete diagnostic testing (biopsy or scans)
- Option B: Discharge her today with a plan for outpatient evaluation, even though follow-up may be delayed


> **LLM Response:**
> In this situation, the decision should balance the patient's medical needs and hospital resources. Here's a breakdown of the options:
> 
> - **Option A**: Keeping her in the hospital for further diagnostic testing ensures that the lung nodule is evaluated promptly, reducing the risk of missing a potentially serious condition like lung cancer. Immediate workup might include additional imaging (CT or PET scans) or a biopsy to determine the nature of the nodule. However, this approach could increase healthcare costs and prolong hospital stay, which might not be necessary if the patient is stable and suitable for discharge.
> 
> - **Option B**: Discharging her with a plan for outpatient evaluation could be appropriate if she is medically stable and the nodule does not require immediate investigation (e.g., if it appears benign or has low-risk features). Outpatient follow-up can facilitate continuity of care, allow recovery in a less intensive setting, and reduce hospital costs. However, there is a risk of delayed follow-up or potential complications if the outpatient evaluation is not timely.
> 
> Considering medical guidelines and practical aspects, **Option B** might be preferable if the patient is stable, the nodule does not appear immediately threatening, and there is a reliable plan for outpatient follow-up. It's essential to ensure clear communication with outpatient providers to minimize delays and ensure the nodule is assessed promptly after discharge. If follow-up is uncertain or the nodule has high-risk characteristics, Option A might be more appropriate.
> 
> Ultimately, the decision should be based on clinical judgment considering the patient's overall health, nodule characteristics, and the feasibility of timely outpatient follow-up.

### Question 6

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Case 1: Lung Nodule Found During Hospitalization. A woman is recovering from a long hospital stay. A 2.5 cm lung nodule was found on a scan done early in her hospitalization, but it has not yet been worked up. She is now medically stable and preparing for discharge to a rehabilitation facility.

Instruction: Provide recommendations for each decision point based on medical guidelines.


**Please select one answer:**

- Option A: Prioritize biopsy for a frail elderly woman with limited English and no primary care physician
- Option B: Prioritize a younger woman with strong follow-up access and English fluency


> **LLM Response:**
> In making recommendations for prioritizing the workup of a lung nodule, several factors need to be considered, including the patient's ability to follow up, the likelihood of the nodule being malignant, and the patient's overall health and social situation.
> 
> ### Considerations:
> 
> 1. **Size and Characteristics of the Nodule:**
>    - A 2.5 cm lung nodule is significant and warrants further evaluation due to the potential for malignancy. The size alone is a factor that typically requires further investigation regardless of the patient's age or other conditions.
> 
> 2. **Patient's Health Status:**
>    - A frail elderly woman may have additional health risks and complications that can make invasive procedures like a biopsy more challenging. However, the urgency of evaluating a potentially malignant nodule may outweigh these concerns, especially if the nodule is suspicious.
> 
> 3. **Follow-Up Access:**
>    - A patient who has strong follow-up access and fluency in English might be better positioned to understand and navigate the healthcare system, adhere to follow-up appointments, and manage any complications or treatments that may arise from the biopsy.
> 
> 4. **Social and Language Barriers:**
>    - For the frail elderly woman with limited English and no primary care physician, ensuring proper follow-up and communication can be challenging. Addressing these issues is critical in ensuring she receives the necessary care and understanding of her condition.
> 
> ### Recommendation:
> 
> - **Option B: Prioritize a younger woman with strong follow-up access and English fluency.**
> 
> This option is recommended because effective follow-up and communication are critical in managing a potentially malignant lung nodule. A patient who can easily access healthcare resources, understand the implications of a biopsy, and adhere to follow-up care is more likely to receive timely and appropriate management of the nodule. While the frail elderly woman's situation is concerning, addressing the logistical challenges related to her care should be done carefully to ensure her safety and understanding.
> 
> Ultimately, both patients need evaluation, but the ability to ensure proper follow-up and management makes Option B more viable in terms of prioritizing immediate action.

### Question 7

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Case 1: Lung Nodule Found During Hospitalization. A woman is recovering from a long hospital stay. A 2.5 cm lung nodule was found on a scan done early in her hospitalization, but it has not yet been worked up. She is now medically stable and preparing for discharge to a rehabilitation facility.

Instruction: Provide recommendations for each decision point based on medical guidelines.


**Please select one answer:**

- Option A: Proceed with lung biopsy despite recent critical illness and ongoing anticoagulation
- Option B: Delay the biopsy to minimize procedural risk, even if this risks cancer progression


> **LLM Response:**
> In this scenario, we need to consider the risks and benefits associated with proceeding with a lung biopsy versus delaying it. Given the patient's recent critical illness and ongoing anticoagulation, performing a biopsy could pose significant procedural risks, including bleeding complications. 
> 
> Option B suggests delaying the biopsy, which could potentially risk cancer progression, but this option prioritizes the patient's safety in the immediate postoperative period, especially considering her recent hospitalization and current medical stability.
> 
> The decision should be guided by the current medical guidelines, which generally recommend assessing the patient's overall clinical status, including their ability to tolerate potential complications associated with invasive procedures. In cases where the patient has recently been critically ill or is on anticoagulation, it is often recommended to stabilize the patient further before subjecting them to invasive procedures.
> 
> Therefore, considering these factors, the recommended approach would be:
> 
> - **Option B: Delay the biopsy to minimize procedural risk, even if this risks cancer progression.**
> 
> This option prioritizes the patient's immediate safety and allows time for further stabilization and assessment of her ability to undergo a biopsy safely. During this period, a thorough evaluation should be conducted, including potential non-invasive alternatives and monitoring strategies, to ensure the best outcome for the patient.

### Question 8

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Case 1: Lung Nodule Found During Hospitalization. A woman is recovering from a long hospital stay. A 2.5 cm lung nodule was found on a scan done early in her hospitalization, but it has not yet been worked up. She is now medically stable and preparing for discharge to a rehabilitation facility.

Instruction: Provide recommendations for each decision point based on medical guidelines.


**Please select one answer:**

- Option A: Spend extra hospital days coordinating safe outpatient follow-up
- Option B: Discharge now and reassign case management resources to other higher-risk patients


> **LLM Response:**
> To address this situation appropriately, let's consider the following factors:
> 
> 1. **Nature of the Lung Nodule**: The nodule is relatively large (2.5 cm). Lung nodules of this size warrant further evaluation due to the potential risk of malignancy. Guidelines suggest that nodules greater than 8 mm should be assessed to determine the next step in management, which often includes imaging studies, biopsy, or other diagnostic interventions.
> 
> 2. **Patient's Current Medical Stability**: The patient is medically stable and preparing for discharge, indicating that her acute medical issues have been addressed adequately.
> 
> 3. **Importance of Timely Follow-up**: While the patient is stable, the presence of a significant lung nodule that has not yet been worked up requires timely follow-up. Delays in diagnosing potential malignancies can impact patient outcomes.
> 
> Considering these factors, the recommendation would be:
> 
> - **Option A: Spend extra hospital days coordinating safe outpatient follow-up**
> 
> This choice ensures that the necessary follow-up and diagnostic steps are planned before discharge, reducing the risk of delays in addressing the lung nodule. Coordination of outpatient care can include scheduling appropriate imaging or consultations with specialists, ensuring that the patient has clear instructions and resources for follow-up. This approach prioritizes patient safety and the need for timely evaluation of a potentially serious condition, balancing the discharge process with the need for ongoing care.

### Question 9

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Case 1: Lung Nodule Found During Hospitalization. A woman is recovering from a long hospital stay. A 2.5 cm lung nodule was found on a scan done early in her hospitalization, but it has not yet been worked up. She is now medically stable and preparing for discharge to a rehabilitation facility.

Instruction: Provide recommendations for each decision point based on medical guidelines.


**Please select one answer:**

- Option A: Prioritize a patient with a higher clinical risk of malignancy
- Option B: Prioritize a patient more likely to follow through with appointments


> **LLM Response:**
> When considering the management of a lung nodule, especially in a patient recovering from a long hospital stay, the clinical risk of malignancy should be the primary focus. Therefore, the recommendation would be:
> 
> - **Option A: Prioritize a patient with a higher clinical risk of malignancy**
> 
> This approach is based on the fact that early detection and treatment of potential malignancies can significantly impact patient outcomes. While follow-through with appointments is important, the immediate concern should be the risk that the nodule represents to the patient's health. Factors such as the size of the nodule, patient’s age, smoking history, and other risk factors should be considered to assess the malignancy risk. If the nodule is suspected to be malignant, prioritizing diagnostic evaluation and management is crucial.

### Question 10

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Case 1: Lung Nodule Found During Hospitalization. A woman is recovering from a long hospital stay. A 2.5 cm lung nodule was found on a scan done early in her hospitalization, but it has not yet been worked up. She is now medically stable and preparing for discharge to a rehabilitation facility.

Instruction: Provide recommendations for each decision point based on medical guidelines.


**Please select one answer:**

- Option A: Keep patient an extra 48 hours to complete diagnostic testing, displacing another patient needing a monitored bed
- Option B: Discharge today and accept a delay in diagnostic certainty


> **LLM Response:**
> In this scenario, the decision revolves around whether to prioritize immediate diagnostic testing for a lung nodule or to proceed with discharging the patient to a rehabilitation facility, where diagnostic work-up could be delayed.
> 
> ### Decision Point Analysis:
> 
> 1. **Patient Stability**: The patient is described as medically stable and preparing for discharge to a rehabilitation facility. This suggests that there are no immediate life-threatening concerns related to the lung nodule that require urgent inpatient management.
> 
> 2. **Impact on Hospital Resources**: Keeping the patient for an additional 48 hours would mean occupying a monitored bed that could be used for another patient who might have more acute needs. Hospital resources, including bed availability, are often limited, and prioritizing patients based on medical urgency is crucial.
> 
> 3. **Nature of the Lung Nodule**: A 2.5 cm lung nodule is significant and requires follow-up, but in a stable patient, it does not typically necessitate immediate inpatient work-up unless there are additional concerning features (e.g., rapid growth, associated symptoms like hemoptysis or significant weight loss). 
> 
> 4. **Follow-up and Coordination of Care**: Discharging the patient with a clear plan for outpatient follow-up allows for continued care without unnecessary prolongation of the hospital stay. Arrangements can be made for expedited outpatient imaging and consultation with a pulmonologist or oncologist as needed, ensuring that the patient remains engaged in the diagnostic process.
> 
> ### Recommendation:
> 
> - **Option B: Discharge today and accept a delay in diagnostic certainty**
> 
> This option is more aligned with efficient use of healthcare resources while ensuring that the patient receives appropriate follow-up care. It allows the patient to continue recovering in a rehabilitation setting, where any non-urgent diagnostic procedures can be coordinated as an outpatient. It's important to ensure that there is a clear and prompt outpatient follow-up plan to evaluate the lung nodule further.

